Francis E Odonnell Jr insider trades
Open-market stock purchases and sales by Francis E Odonnell Jr, Chief Executive Officer at Inhibitor Therapeutics, Inc, from SEC Form 4 filings since Feb 24, 2009.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 4, 2026 | INTI Inhibitor Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- INTI Inhibitor Therapeutics, Inc: other filings, last May 4, 2026
- BDSI Biodelivery Sciences International Inc: 58 sales, last May 11, 2020
- HPPI HedgePath Pharmaceuticals, Inc: 2 buys, 1 sale, last Jun 15, 2016
- ABPI Accentia Biopharmaceuticals Inc: 1 buy, 1 sale, last Nov 8, 2013
- CBTEQ HedgePath Pharmaceuticals, Inc: other filings, last Aug 13, 2013
- BVTI.OB Biovest International Inc: other filings, last Jul 9, 2013
Get free alerts when Francis E Odonnell Jr files a new trade →